SecBot SecBot
Insider Cluster (4 insiders) ·Filed Sep 15, 2026

NBIX

NEUROCRINE BIOSCIENCES INC
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $696K total
Actionable Insight • Neutral

Insider cluster shows 2 insiders with open-market sales totaling $493K (CFO Abernethy sold 2,311 shares for $363K; another officer sold 826 shares for $130K) plus non-cash tax-withholding surrenders by the CEO and CFO (~$1.1M combined, $0 economic value) and a director grant. Total open-market sales of $493K represent ~0.003% of NBIX's $16.0B market cap, trivial and routine. Sales are liquidity/vesting-driven (tax withholding, small sizes), not informational. No material directional signal.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$149.50
T+0 close · Sep 15, 2026 · via day close
Latest settled
−9.09%
T+20 · $135.91 · next T+60 in 23d
Vs SPY
−11.15%
α at T+20
Latest observation
+15.51%
T+41 · FF3 residual α
  1. T+0 · Sep 16 $149.50entry
  2. T+1 · 2mo ago +1.56%α +0.42% · $151.83
  3. T+5 · 8w ago −6.70%α −9.26% · $139.49
  4. T+20 · 5w ago −9.09%α −11.15% · $135.91
  5. T+43 · todayOpen
  6. T+60 · in 23d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Insider cluster shows 2 insiders with open-market sales totaling $493K (CFO Abernethy sold 2,311 shares for $363K; another officer sold 826 shares for $130K) plus non-cash tax-withholding surrenders by the CEO and CFO (~$1.1M combined, $0 economic value) and a director grant. Total open-market sales of $493K represent ~0.003% of NBIX's $16.0B market cap, trivial and routine. Sales are liquidity/vesting-driven (tax withholding, small sizes), not informational. No material directional signal.

Key Financial Metrics

Direction
selling
Total Value
$493.0K
Insiders
4

Financial Impact

Not specified

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NBIX-1789506185700

Track record

30 reports on NBIX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +27.40% at T+60 after the Apr 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $174.41 Now $165.31 −5.22% settles Dec 10
  2. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  3. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  4. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  5. Nov 2, 202614d ago Press Release Bullish 6/10 No price data
  6. Nov 2, 202614d ago 144 Neutral 2/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  7. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  8. Oct 30, 202617d ago 144 Neutral 1/10 Entry $145.35 Now $165.31 +13.73% settles Dec 1
  9. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $146.10 Now $165.31 +13.15% settles Nov 30
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $145.53 Now $165.31 +13.59% settles Nov 25
Showing 10 of 30

US Market Status

Market Closed · Opens in 7h 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026